Beyond the Product: New Growth Drivers for Medical Technology Companies Through AI in Sales and Service
Rising competitive pressure, new customer expectations, stricter regulatory requirements, and increasing costs are forcing medical technology companies to rethink their business models.
Salesforce helps shape a new approach that goes beyond the product itself: it covers the entire lifecycle, from the first customer interaction through sales and service to long-term customer retention.
Why this matters:
- The global medical technology market continues to grow strongly: according to Fortune Business Insights, it is expected to reach a volume of around USD 886.7 billion by 2032. Competitive pressure in the market is increasing steadily.
- Physicians are expecting new interaction models: according to Bain, 50 percent of HCPs now prefer predominantly or fully digital interaction with sales representatives.
- Data is becoming a strategic success factor: around 30 percent of global data volume is generated in healthcare (Fortune Business Insights). The challenge is not a lack of data, but connecting it meaningfully.
- Hybrid instead of purely in-person: customers now expect flexible, cross-channel, and consistent engagement, just as they have long been used to in other industries.
How Agentforce specifically supports sales and service in MedTech
This is exactly where Agentforce comes in: moving away from CRM as a passive data repository toward an active, intelligent platform that enables teams to translate data into concrete next steps while increasing efficiency and productivity. Agentforce unifies structured and unstructured clinical, medical, and commercial data from multiple sources on a secure, trusted platform where employees and AI agents collaborate seamlessly.
In sales, autonomous AI agents can, for example, pre-qualify leads, consolidate relevant information from multiple data sources, and recommend the most meaningful next steps to sales representatives. This reduces manual effort and helps teams focus on the interactions that have the greatest impact on pipeline and revenue.
In customer service, inquiries can be prioritized faster, cases can be assigned automatically, and recurring workflows can be standardized. At the same time, it becomes possible to act proactively, for example when data signals from devices, service histories, or customer interactions indicate a need for action. Reactive support becomes a forward-looking service approach that can unlock additional revenue streams.
Marketing and KOL engagement benefit as well. As HCPs grow more selective and increasingly favor digital channels, success depends on delivering personalized, relevant communication rather than broad, generic outreach. The goal is to better coordinate interactions with professional audiences across the entire commercial journey and provide the right information at the right time.
Conclusion: For medical technology companies, the issue is not about introducing AI selectively or modernizing an existing CRM in isolation. It is about creating a resilient foundation for growth: with connected data, more efficient processes, trustworthy automation, and AI support that not only relieves employees of routine work but also helps them perform more successfully. This enables a shift from reactive work to a connected, more productive, and customer-centric model, creating the opportunity to drive growth not only through products, but across the entire commercial lifecycle.
